Clapper, Patti, Schweizer and Mason

(415) 332-4262

Treatment Research

Beyond providing the best legal representation in the United States, Clapper Patti Schweizer & Mason also is dedicated to providing the most up-to-date resources on mesothelioma treatment options for our clients. Clinical research into better, more effective ways to prevent, diagnose, and treat mesothelioma are ongoing both here in the United States and worldwide.

This section of our website is devoted to offering overviews of the latest mesothelioma research and treatment currently being investigated by the National Cancer Institute (NCI) as well as other worldwide scientific studies. We hope the information provided here complements what your mesothelioma doctor or medical team is telling you. For more on clinical trials for mesothelioma, click here.

Dec 3, 2012 - Experimental Drug for Mesothelioma Treatment Shows Great Promise

Preliminary findings from a Phase I Clinical Trial of a new drug for patients diagnosed with mesothelioma show some success in preventing the spread of this fatal cancer in patients lacking NF2, an active tumor suppressor gene.

View the full article

Nov 28, 2012 - Could a Cold Virus Kill Mesothelioma?

Scientists at the Salk Institute for Biological Studies have discovered that adenovirus, a type of cold virus, can interrupt the cell's molecular structure and activity that's involved in cancer growth, replication and suppression, suggesting that these viruses may also be used as an effective mesothelioma treatment. The results from the research was published on October 11 in Cell.

View the full article

Nov 26, 2012 - Dry Mesothelioma Offers Unique Set of Risks

Malignant pleural mesothelioma presenting without effusion is referred to as "dry mesothelioma." Dry mesothelioma can present more of a diagnostic challenge, however current research suggests that using ultrasound-guided cutting needle biopsies are effective and safe in diagnosing patients with pleural thickenings suspect for malignant mesothelioma without pleural effusion or with loculated...

View the full article

Oct 16, 2012 - Certain Skin Tumors May Signal Higher Risk of Mesothelioma

University of Hawaii researchers believe that certain types of skin spots that are caused by a mutated BAP1 genetic profile may indicate a heightened risk of mesothelioma, a rare form of cancer caused by exposure to asbestos.

View the full article

Oct 12, 2012 - Mesothelioma Test Acquired by International Diagnostic Company

In a business move that has far reaching implications for mesothelioma research, the biotechnology company Castle Biosciences has acquired all current and future rights to a mesothelioma diagnostic technology created at Brigham and Women’s Hospital – one of the world’s leading cancer research facilities. The company is most interested in the gene expression test...

View the full article

Oct 11, 2012 - New Blood Test for Mesothelioma May Soon Be Available

Rachel Ostroff, who works for SomaLogic, has published new research in PLOS ONE that suggests that a new blood test may be available soon that could help in testing for mesothelioma.

View the full article

Sep 5, 2012 - New Form of Immunotherapy for Mesothelioma Progresses

A new clinical trial is underway that is investigating a possible new procedure for use as an advanced cancer and mesothelioma treatment using blood cells known as peripheral blood cells. These cells are modified and grown in a laboratory and then used to target and destroy cancer cells.

View the full article

Sep 4, 2012 - New Understanding of How Chemotherapy Drug Works in Mesothelioma Patients

During a recent research study, scientists discovered they could use levels of thymidylate synthase in the blood to predict and gauge how effective Pemetrexed, a common chemotherapy drug used in mesothelioma treatments, would be in killing off malignant cells.

View the full article

Aug 30, 2012 - Mesothelioma Treatment May Increase Resistance to Chemotherapy

Collaborative study finds certain chemotherapies may actually increase a mesothelioma patient's resistance to the very treatment that could help reduce the cancer. Researchers have discovered a key protein that actually makes certain types of cancer more resistant to chemotherapy. Unfortunately, this protein is sometimes created by genes damaged by chemotherapy. In essence, the most widely...

View the full article

Aug 29, 2012 - Compound in Plants Can Kill Mesothelioma Cells

A recent study has revealed that Quercetin, a plant-derived flavonol found in in fruits, vegetables, leaves and grains, may be effective as an alternative mesothelioma treatment causing malignant mesothelioma cell death.

View the full article

Aug 28, 2012 - Controversy Around Use of Suntinib for Mesothelioma Treatment

There have been conflicting reports about the use of a drug called Suntinib, marketed as Sutent, causing controversy over whether it is suitable to use in mesothelioma treatments. Sutent has been used to treat gastrointestinal stromal tumors in people with tumors that were not treated successfully with imatinib (Gleevec) or people who cannot take imatinib.

View the full article

Aug 27, 2012 - Phase II Study of Vinorelbine Hints at Use As Mesothelioma Treatment

According to a study by the Department of Medical Oncology at St Bartholomew's Hospital and the London Lung Cancer Group, Vinorelbine, marketed as Navelbine®, may play some part in fighting mesothelioma in the near future. The two organizations examined vinorelbine as a first-line treatment for malignant pleural mesothelioma and hint that it may prove an effective second-line therapy as well.

View the full article

Aug 24, 2012 - Phase II Trial Examines Cediranib as a Treatment for Mesothelioma

Researchers from the University of Chicago recently completed a Phase II clinical trial of Cediranib as a potential new treatment for malignant mesothelioma. Presented at the annual meeting of the American Society of Clinical Oncology, the research examined vascular endothelial growth factor (VEGF) and its response to Cediranib as a measurement of its effectiveness against mesothelioma.

View the full article

Aug 23, 2012 - Navelbine as a Mesothelioma Treatment

Navelbine, generic name of vinorelbine, is a chemotherapy drug being investigated in clinical trials for mesothelioma and shows promise in being an effective frontline as well as relapse treatment.

View the full article

Aug 20, 2012 - Potential New Diagnostic and Prognostic Marker for Pleural Mesothelioma

Scientists from the Department of Thoracic Surgery at the Hyogo College of Medicine in Nishinomiya, Japan shows that by examining circulating endothelial cells (CEC) mesothelioma doctors can very accurately identify patients suffering from this deadly asbestos disease. The study results, published in the annals of Surgical Oncology, also demonstrated that levels of CECs can be used as a...

View the full article

Aug 15, 2012 - Vinorelbine (Navelbine) Used for Mesothelioma Relapse

Clinical trials are investigating the use of Vinorelbine for patients who experience mesothelioma relapse. Vinorelbine has shown some promising results as a frontline treatment and researchers wanted to see if it might also be effective in treating patients after relapse.

View the full article

Aug 14, 2012 - Vinorelbine and Oxaliplatin Chemotherapy Shows Promise as Mesothelioma Treatment

Results of a phase II Clinical Trial using a combination of vinorelbine and oxaplatin as a treatment for malignant mesothelioma.

View the full article

Aug 13, 2012 - Bayer's New Antibody-Drug Combo Earns Orphan Drug Designation

Bayer has a new anti-cancer drug, BAY94-9343, recently granted Orphan status that is currently being tested in Phase I Clinical trials. The hope is that, if successful in trials, this could prove to be a more effective treatment for mesothelioma.

View the full article

Jul 23, 2012 - Doctors Investigating Everolimus as New Drug Therapy for Mesothelioma

Everolimus, marketed as Afinitor, is a multipurpose drug currently being investigated in a Phase II clinical trial as a viable mesothelioma treatment.

View the full article

Jul 19, 2012 - Avastin and Tarceva Undergo Clinical Trials as Combined Treatment for Mesothelioma

A Phase II Clinical Trial is investigating the efficacy of combining Avastin and Erlotinib as a mesothelioma treatment.

View the full article

Jun 29, 2012 - Mesothelioma Treatment May Make Monitoring the Cancer More Difficult

A new study published in the Journal of Cancer in June reveals that a relatively common mesothelioma treatment using talc actually could interfere with monitoring of this deadly form of asbestos cancer. They suggest that more studies be conducted to find ways to be able to continue to use this type of mesothelioma treatment without the unwanted side effect.

View the full article

Jun 28, 2012 - New Drug Perifosine Shows Potential as Novel Treatment for Mesothelioma

Perifosine's activity was tested on human mesothelial cells and different mesothelioma cell lines, both as a single agent as well as a combined therapy where malignant mesothelioma cells were treated with cisplatin as well. Results from the study showed significant cell toxicity, giving evidence that perifosine should be considered as a novel new treatment for mesothelioma. data...

View the full article

Jun 27, 2012 - Study Supports Photodynamic Therapy Combined with Lung-Sparing Surgery as MesotheliomaTreatment

Multi-modality treatments for mesothelioma have increasingly proven to be more effective, and this study shows one combination of therapies led to longer survival times, especially for those diagnosed with epithelial mesothelioma.

View the full article

Jun 26, 2012 - Patent Granted for Malignant Pleural Mesothelioma Treatment

MolMed, an Italian biotechnology company, has been granted a patent for the use of NGR-hTNF, a drug that has shown initial success as a mesothelioma treatment. Currently, standard mesothelioma treatments have little effect on this deadly disease nicknamed 'asbestos cancer.'

View the full article

Jun 25, 2012 - Mesothelin a Promising Target for Mesothelioma Treatment

Dr. Hassan, medical oncologist and senior investigator at the National Cancer Institute (NCI) is researching novel therapies for the treatment of malignant mesothelioma. Clinical trials Hassan is currently conducting are investigating two different immunotherapy agents targeting the tumor antigen mesothelin.

View the full article

Jun 20, 2012 - Gene Therapy for Mesothelioma Targets Inhibitory Protein 1 Promoter System

Using a gene expressed in malignant pleural mesothelioma, scientists research for a better mesothelioma treatment that could slow the progression of this aggressive cancer caused by asbestos exposure.

View the full article

Jun 19, 2012 - Hemithoracic Radiation May Be Appropriate Treatment for Mesothelioma Patients

Australian researchers have found some evidence, based upon a clinical study, that radiation therapy can provide the best response rates of any single mesothelioma treatment, particularly for patients with pleural mesothelioma confined to one side of the chest.

View the full article

Jun 18, 2012 - Beneficial Use of Intrathoracic Chemotherapy Confirmed

Administration of intrapleural chemotherapy preceded by a thoracic cytoreduction of both parietal and involved visceral pleura was used in a study to investigate the possibility of removing all visible evidence of malignant mesothelioma.

View the full article

Jun 18, 2012 - Common Flavonoid Kills Mesothelioma Cells

Researchers investigate using Resveratrol, a common flavonoid found in red grapes that has shown some promise in slowing the progression of cancer, as a novel mesothelioma treatment.

View the full article

Jun 14, 2012 - University of Hawaii Leads the Way in Mesothelioma Research

University of Hawaii researchers have discovered a critical link between the protein HMGB1 (high-mobility group protein 1) and growth of malignant mesothelial cells.

View the full article

Jun 14, 2012 - Searching for a Mesothelioma Blood Test

Scientists are searching for ways to diagnose mesothelioma more accurately and earlier using blood tests.

View the full article

Jun 13, 2012 - Study Demonstrates Difficulty in Diagnosing Malignant Peritoneal Mesothelioma

Malignant Peritoneal Mesothelioma, one type of asbestos cancer, can be very difficult to diagnose as mesothelioma has a long latency period and the symptoms of mesothelioma mimic other more common illnesses that lead to misdiagnosis.

View the full article

Jun 12, 2012 - Better Way to Treat Mesothelioma with Antibody-based Cancer Agents

Scientists are looking for more effective mesothelioma treatments using antigen based therapies. In this study, researchers examined the role of recombinant immunotoxins (RIT) as modified cancer agents.

View the full article

Jun 12, 2012 - Case Study Exemplifies Challenges in Diagnosing Peritoneal Mesothelioma

Malignant peritoneal mesothelioma is the second most common form of this deadly cancer caused by prior exposure to asbestos. It represents roughly 30% of all mesothelioma cancers and is widely regarded as one of the most aggressive forms of the disease. Malignant peritoneal mesothelioma can sometimes be very difficult to diagnose. Many of the symptoms are similar to those...

View the full article

Jun 11, 2012 - New International Study Seeks to Understand Death in Mesothelioma Patients

Researchers from the UK and Australia united efforts to investigate the exact mechanism of mesothelioma that causes death.

View the full article

Jun 9, 2012 - Mesothelioma Treatment using Pleurectomy with Intraoperative Photodynamic Therapy

Scientists suggest a successful mesothelioma treatment in some cases could be combining pleurectomy procedures with interoperative photodynamic therapy (PTD).

View the full article

Jun 4, 2012 - Green Tea Component Fights Mesothelioma

A recent study from Italy shows that components from green tea can be used as a mesothelioma treatment.

View the full article

May 31, 2012 - Chemotherapy Drug Combination for Mesothelioma Treatment Investigated

A combination of Cisplatin, a front line chemotherapy drug used in mesothelioma treatments, and Gemcitabine (Gemzar) showed success in a recent Phase II Clinical Trial for pleural mesothelioma.

View the full article

May 31, 2012 - Two Popular Mesothelioma Drugs Combined

Clinical Trial Combining Cisplatin and Pemetrexed (Alimta) shows success as a treatment for mesthelioma.

View the full article

May 30, 2012 - Concurrent Chemoradiotherapy as Treatment for Malignant Peritoneal Mesothelioma

Researchers in Tokyo have discovered that concurrent chemotherapy and radiation therapy lead to improved treatment for peritoneal mesothelioma.

View the full article

May 30, 2012 - Key to Success with Radiotherapy for Mesothelioma & EPP Surgery

As with any form of treatment, the more familiar a doctor or surgeon is, the better the results will be. This was confirmed recently by a retrospective study at Duke University’s Medical Center. Researchers examined several cases of mesothelioma that were treated with Intensity Modulated Radiation Therapy (IMRT) and discovered that those patients treated in the past when the...

View the full article

May 29, 2012 - Body Clock Plays Part in Mesothelioma Growth

Researchers have discovered a chemical called BMAL1 that plays a role in regulating the circadian rhythm (body's internal clock) may be helpful in developing an effective mesothelioma treatment.

View the full article

May 26, 2012 - Could Anti-angiogenic Drugs Fight Malignant Mesothelioma?

Anti-angiogenic drugs could serve as an effective mesothelioma treatment by starving tumors of blood and nutrients that they need to grow.

View the full article

May 20, 2012 - Certain Biphasic Peritoneal Mesotheliomas Should Be Excluded from Bimodal Treatment

Results from a small study lead researchers to advise using caution with bimodal treatment if diagnosed with biphasic peritoneal mesothelioma.

View the full article

May 11, 2012 - Protein Markers Help Distinguish Mesothelioma from Adenocarcinoma

Researchers have found protein markers that can help distinguish malignant pleural mesothelioma from adenocarcinoma.

View the full article

May 9, 2012 - Protein Analysis Helps in Mesothelioma Prognosis

Analysis of particular protein markers helps mesothelioma specialists more accurately predict prognosis.

View the full article

May 8, 2012 - Protein Expression Linked to Better Chemo Results in Mesothelioma Patients

Mesothelioma researchers have discovered that overexpression of a certain protein can possibly predict chemotherapy results. Not only do mesothelioma patients with this certain protein anomaly experience better results from chemotherapy, they also experience significantly improved survival rates. This is good news for many mesothelioma patients. In spite of new breakthroughs and...

View the full article

May 3, 2012 - Complete Parietal Peritonectomy Provides Better Results than Cytoreductive Surgery for Some Mesothelioma Patients

For most patients with diffuse malignant peritoneal mesothelioma (DMPM) their treatment regimen will likely include some form of radical surgery to mitigate the effects of tumor growth. While many mesothelioma surgeons still advocate cytoreductive surgery, a recent study published in the Annals of Surgical Oncology concludes that parietal peritonectomy provides better post-surgical...

View the full article

May 3, 2012 - Study Confirms Asbestos Link to Rare form of Tunica Vaginalis Testis Mesothelioma

The results of a recent study published in the British Journal of Urology International (BJUI) reaffirm the link between asbestos and a rare form of mesothelioma which develops in the testes. Mesothelioma of the tunica vaginalis testis is a very rare form of asbestos cancer that attacks the membrane covering the testicles in men who have had prior asbestos exposure. In the...

View the full article

May 1, 2012 - Nanobubbles Could Offer Chemotherapy Delivery Option for Mesothelioma Patients

New research using Nanobubbles as method of delivering chemotherapy treatment for mesothelioma patients shows great promise in reducing side effects.

View the full article

May 1, 2012 - Scientists Discover Micro RNAs Aid Earlier Mesothelioma Diagnosis

Australian researchers looking for a way to detect mesothelioma earlier in the disease’s progression have locked on to microRNAs as possible indicators. It is their hope that a test can be devised using these tiny molecules to positively identify the presence of mesothelioma cancers in patients without having to wait until symptoms are noticed. Since mesothelioma has such...

View the full article

Apr 29, 2012 - Diagnostics Company Develops microRNA Test for Mesothelioma

Rosetta Genomics research a microRNA-based diagnostic tool for differential diagnosis of MPM from gastrointestinal and lung adenocarcinoma and other carcinomas.

View the full article

Apr 28, 2012 - Research Affirms Pallliative Care Vital for Treatment of Mesothelioma

Researchers shows pain control not given enough emphasis by doctors treating mesothelioma, an incurable form of asbestos cancer.

View the full article

Apr 26, 2012 - Italian Research Dilemma Underscores the Difficulty of Discovering New Treatments for Mesothelioma

Italian Researchers investigating the role of different genes in diagnosing mesothelioma were hampered in their efforts in several ways.

View the full article

Apr 23, 2012 - Higher Risk at Low-Volume Hospitals for Mesothelioma Patients Undergoing Complex Surgery

Researchers discovered that those diagnosed with mesothelioma who have surgery as a treatment option fare better at higher-volume hospitals.

View the full article

Apr 22, 2012 - Chemotherapy Without the Side Effects: New Hope for Mesothelioma Patients

A new way of delivering chemotherapy drugs for mesothelioma may reduce or eliminate side effects.

View the full article

Apr 19, 2012 - Could Fireflies Open a New Avenue in Mesothelioma Treatment?

New study shows the chemical luminescence created by fireflies may aid surgeons in treating mesothelioma.

View the full article

Apr 12, 2012 - Study Reaffirms the Use of PET-CT Scans in Post-Surgical Mesothelioma Patients

Malignant Pleural Mesothelioma (MPM) is notoriously difficult to treat—usually requiring radical surgery, extensive chemotherapy, and radiation treatments. However, even these cannot stop the disease. Mesothelioma is invariably fatal and all doctors and patients can hope for is to delay the progress of the cancer for as long as possible while maintaining as high quality a...

View the full article

Apr 10, 2012 - Pond Scum May Be Able to Identify Mesothelioma Cells In Patient's Blood

Investigation continues to further research that showed that pond scum, Euglena, may prove useful in identifying cancer cells, including malignant mesothelial cells, which would aid in earlier diagnosing and better treatment options for mesothelioma.

View the full article

Mar 30, 2012 - Thoracic Surgeons at UCSF Listed as 2012 U.S. Top Doctors

The asbestos law firm of Clapper, Patti, Schweizer & Mason spread the news of surgeons from University of California San Francisco (UCSF) being included as U.S.News Top Doctors. UCSF is one of the top medical facilities that diagnoses mesothelioma, a form of asbestos cancer, and offers innovative and minimally invasive thoracic surgery as a treatment. CPSM has been representing those...

View the full article

Feb 13, 2012 - Unique Immunotherapy Holds Promise as Mesothelioma Treatment

Scientists from Australia investigate a new method of immunotherapy as a more effective treatment for mesothelioma, a fatal cancer caused by exposure to asbestos.

View the full article

Jan 4, 2012 - Mesothelioma Vaccine One Step Closer to Reality

Recent results from a study conducted by the Mayo Clinic shows high promise of discovering a vaccine that could be used as a more effective mesothelioma treatment.

View the full article

Dec 19, 2011 - Biomarkers Help Doctors Determine Best Mesothelioma Treatment Course

New research from the Medical University of Vienna shows promising results of how certain biomarkers may help doctors determine the best treatment course for mesothelioma patients.

View the full article

Dec 19, 2011 - Potential New Method Of Mesothelioma Diagnosis Being Evaluated

Researchers from Egypt and Japan have discovered that use of an acid-induced fluorescence is an effective photosensitizer for photodynamic diagnosis (PDD) for mesothelioma and other types of cancer.

View the full article

Dec 16, 2011 - Attacking Mesothelioma's Growth Factor- An Alternative Treatment

Scientists explore the role of epidermal growth factor receptors in malignant pleural mesothelioma in hopes of finding a more effective treatment for this fatal type of asbestos cancer.

View the full article

Nov 30, 2011 - Scientists Develop New Breath Test for Mesothelioma Diagnosis

Researchers from the Netherlands and Italy have discovered that a device called Cyranose 320 can detect mesothelioma in patients. Such a tool could lead to much earlier diagnosis of this type of asbestos cancer, which would greatly improve treatment success.

View the full article

Nov 29, 2011 - Promising Preclinical Trials of Mesothelioma Treatment Using New Cancer Drug

Plexxikon Inc. has conducted preclinical trials using a novel agent, PLX3397, with very promising initial results. Phase II trials will continue to explore the efficacy of this drug as a viable mesothelioma treatment.

View the full article

Nov 23, 2011 - Scientists Wage Viral Warfare Against Mesothelioma

Mesothelioma is a fatal cancer caused by exposure to asbestos that does not typically respond well to traditional treatments. Researchers hope to use altered viruses as a more effective way to treat this type of asbestos cancer.

View the full article

Nov 15, 2011 - Optimizing Adjuvant Chemotherapy & Mesothelioma

Lung Cancer Journal recently shared results of an Austrian study that suggest that biomarkers may be useful in clinical practice for selecting mesothelioma patients with complete resection for optimal adjuvant chemotherapy.

View the full article

Nov 7, 2011 - Immune System Manipulation Possible Effective Mesothelioma Treatment

After having success in using a form of immunotherapy in initial trials with mice, this new method of treatment will be offered to those diagnosed with mesothelioma as part of a clinical trial.

View the full article

Oct 31, 2011 - Company Files With FDA for New Mesothelioma Treatment

Pinnacle Biologics recently filed paperwork with the FDA for approval for a new drug, Photofrin, that has been shown to be a potentially effective treatment for mesothelioma, especially when used in conjunction with other therapies.

View the full article

Oct 20, 2011 - New Possible Mesothelioma Treatment Approved by FDA

A new anti-cancer drug, Xalkori, has been approved in combination with a diagnostic test that is specifically designed to treat non-small cell lung cancers, such as mesothelioma.

View the full article

Oct 7, 2011 - New Compound JBIR-23 Causes Cell Death in Mesothelioma

Researchers have discovered a new compound, JBIR-23, which shows signs of causing apoptosis, or cell death, in mesothelioma patients.

View the full article

Oct 7, 2011 - Drug Found to Suppress Migration of Malignant Mesothelioma

Scientists have found a Urinary Trypsin Inhibitor (UTI) which interferes with migration and growth of mesothelioma cells, thereby slowing down the progression of the cancer and prolonging survival times.

View the full article

Oct 6, 2011 - New Wave of Mesothelioma Doctors Seek to Better Understand Asbestos Cancer

Mesothelioma specialists are hoping that by taking a new approach to investigative research, new clues will be found that will help prevent, treat, and even ond day soon cure mesothelioma.

View the full article

Sep 12, 2011 - Engineered Virus Identifies and Infects Mesothelioma Cells

A new oncolytic virus, JX-594, is showing promise as a treatment for mesothelioma, targeting malignant cells while leaving healthy ones alone.

View the full article

Aug 30, 2011 - Scientists Find Genetic Risk Factor for Mesothelioma Diagnosis

A team of researchers from Philadelphia have identified a genetic risk factor associated with mesothelioma, a fatal form of cancer caused by asbestos exposure.

View the full article

Aug 22, 2011 - Onconase Shows Promise as Treatment for Mesothelioma

In the phase III trial, patients diagnosed with malignant pleural mesothelioma were selected with the hope that Onconase would create antitumor activity, slowing the progression of the cancer. Clinical performance of Onconase was promising for both biphasic and epithelial mesothelioma tumors.

View the full article

Aug 15, 2011 - Phase III Trial Offers Hope for Mesothelioma Victims

Results were recently published regarding a clinical trial researching the efficacy of using a combination of two drugs, Bevacizumab and Erlotinib, to treat mesothelioma.

View the full article

Aug 12, 2011 - New Research Sheds Light On Extra-Pleural Pneumonectomy as a Mesothelioma Treatment

Research regarding using surgical resection for the treatment of mesothelioma presents conflicting results as to whether extrapleural pneumonectomy is worth the risk of complications that can arise after the procedure has been completed.

View the full article

Aug 2, 2011 - Antioxidants Shown to Combat Mesothelioma Tumor Growth

A new study out of the Philadelphia Cancer Center suggests antioxidants may help fight mesothelioma and extend survival times.

View the full article

Jul 8, 2011 - Japan Searches for Asbestos Replacement & Mesothelioma Biomarker

Japan's Ministry of the Environment is investigating the use of forsterite as an alternative to chyrsotile asbestos and helped fund a research study using a biomarker to measure toxicity of both minerals.

View the full article

Jul 8, 2011 - Recommendations for Diagnosing Peritoneal Mesothelioma

Researchers from the Osaka Medical Center for Cancer release a case study and recommendations for diagnosing Malignant Peritoneal Mesothelioma (MPM), one of the more rare forms of cancer caused by asbestos exposure.

View the full article

Jun 29, 2011 - University of Hawaii Receives an Anonymous $3.58M for Mesothelioma Research

The University of Hawaii Cancer Center has received an anonymous gift of 3.58 million specifically earmarked for research pertaining to mesothelioma, a deadly cancer caused by asbestos.

View the full article

Jun 10, 2011 - New Mesothelioma Radiation Therapy Needs More Testing

The US Department of Health and Human Services (HHS) recently called into question the safety of a new type of radiation therapy used to treat the asbestos related cancer mesothelioma. Stereotactic Body Radiation Therapy (SBRT) has been used in several patients but HHS opponents are worried that there isn’t enough evidence in the form of empirical studies to definitively say...

View the full article

Jun 6, 2011 - Cell Proteins Could Be Early Mesothelioma Indicator

Clinical trial reveals that cell protein mutations could help to detect mesothelioma before it becomes malignant.

View the full article

May 18, 2011 - Fungal Metabolite Shows Promise as Mesothelioma Treatment

A new research study uncovered a fungal metabolite called Fusarisetin A that may prove useful as a mesothelioma treatment.

View the full article

May 16, 2011 - Common Cancer Therapy May Be Harmful To Mesothelioma Patients

Recent study believes that a common cancer therapy, prohylactic irradiation therapy, does not benefit and may harm patients diagnosed with mesothelioma.

View the full article

May 16, 2011 - New Drug, Temsirolimus, May Be Effective for Mesothelioma Treatment

A new drug, Temsirolimus, that has traditionally been used to treat kidney cancer shows promise as being an effective treatment for mesothelioma. Under the brand name Torisel, clinical trials have shown that this drug combats the growth of malignant pleural mesothelioma tumors.

View the full article

May 13, 2011 - International Symposium on Lung-Sparing Mesothelioma Therapies

The first International Symposium on Lung-Sparing Mesothelioma Therapies is being held this month, on May 21st, by the UCLA Mesothelioma Research Program, in Santa Monica, CA.

View the full article

Apr 30, 2011 - New Drug Treatment for Mesothelioma Gives Hope

A new combination drug therapy of low dose interferon alfa-2b and Lovastatin, a cholesterol reducing drug, has shown promising results as a treatment for mesothelioma as well as other rare and fatal cancers. The new combination of drugs is being investigated to treat aggressive cancers that have shown no improvement with traditional therapies.

View the full article

Apr 5, 2011 - Genetically Engineered Virus May Fight Malignant Pleural Mesothelioma

This study investigated the effectiveness of a genetically modified version of Newcastle disease virus (NDV) when reprogrammed to attack mesothelioma cells. Newcastle disease is a contagious bird disease first discovered in England that might be able to be used as a form of mesothelioma treatment.

View the full article

Mar 28, 2011 - Alimta Approved by FDA as Mesothelioma Drug Treatment

Alimta, also marketed as Pemetrexed, is approved by the FDA for use in chemotherapy treatments for malignant mesothelioma. Chemotherapy is a frontline, standard treatment often used as a first line of attack for those diagnosed with mesothelioma.

View the full article

Mar 28, 2011 - Bionomics Investigates New Drug Treatment for Mesothelioma

Bionomics, an Australian drug development company, is investigating the use of a new anti-cancer drug, BNC105, as a treatment for malignant mesothelioma. Clinical Trials are underway in hopes of finding a more effective way to slow the progression of this asbestos cancer.

View the full article

Feb 22, 2011 - Less Side Effects with Combination of Carboplatin & Pemetrexed

Research shows that using a combination of two approved chemotherapy drugs for mesothelioma result in fewer side effects and is now recommended for those patients who qualify for a combination treatment.

View the full article

Feb 15, 2011 - New Option for Pleural Mesothelioma Treatment

New option for malignant pleural mesothelioma receives international backing after studies show using Raltitrexed and Cisplatin as a combination chemotherapy treatment is more effective in stopping the progression of this type of asbestos cancer.

View the full article

Feb 7, 2011 - Recall of Drug that Eases Side Effects of Cisplatin Used in Mesothelioma Treatments

A drug commonly used to ease side effects of cisplatin, which is often used in treating mesothelioma, has been voluntarily recalled by American Regent due to presence of glass particles.

View the full article

Jan 7, 2011 - Vaccine for Mesothelioma Is Safe

Researchers have discovered a type of vaccine to be used as a mesothelioma treatment involving the body's own Dendritic cells found in the blood stream. This type of treatment is often referred to as immunotherapy, where something found in the patient's own body is used to fight off disease.

View the full article

Jan 5, 2011 - Biomarker Discovered to Predict Mesothelioma & Provide Early Intervention

Researchers from Japan suggest using VEGF levels as a way to diagnose as well as accurately predict prognosis of malignant pleural mesothelioma.

View the full article

Jan 2, 2011 - Mouse Model Shows Potential for Finding Cure for Mesothelioma

A recent study form the University of Australia recommends use of a MexTAg mouse model in exploring efficacy of new therapies that could prevent or treat mesothelioma in humans.

View the full article

Nov 14, 2010 - Music Therapy Helps Alleviate Mesothelioma Cancer Pain

A recent review of research shows that music therapy can be a useful addition to cancer treatments, including helping ease pain from symptoms of mesothelioma and reducing side effects from chemotherapy treatments for mesothelioma.

View the full article

Nov 2, 2010 - New Nausea Control for Mesothelioma Patients Undergoing Treatment

Researchers have found a viable alternative for controlling nausea and vomiting, common side effects for mesothelioma patients who are undergoing chemotherapy treatment.

View the full article

Nov 1, 2010 - Combination Chemotherapy for Elderly Mesothelioma Patients

After completing a Phase III clinical trial, researchers from France shared promising results that elderly patients diagnosed with non-small cell lung cancer, like mesothelioma, would benefit from combination versus single agent chemotherapy.

View the full article

Nov 1, 2010 - Integrative Treatment Approach for Mesothelioma

Those diagnosed with advanced stage mesothelioma may want to consider adding integrative medicine approaches to standard treatment options.

View the full article

Oct 31, 2010 - Mesothelioma: Conversations When Cancer is Incurable

End of life conversations are challenging to have, yet necessary when one is diagnosed with mesothelioma, an incurable cancer often diagnosed in late stages.

View the full article

Oct 18, 2010 - New Peritoneal Mesothelioma Treatment Protocol Successful

Researchers from Columbia University in New York have discovered a safe and effective approach for treating malignant peritoneal mesothelioma.

View the full article

Oct 17, 2010 - TGFBI, Radiotherapy & Mesothelioma Treatment

A recent study from the Columbia University in New York indicates that lowering TGFBI levels can enhance radiotherapy effects for patients with mesothelioma.

View the full article

Oct 5, 2010 - Imaging of Malignant Pleural Mesothelioma Predicts Survival

A recent study from the University of Western Australia reveals how imaging can help with diagnosis as well as predict survival for patients diagnosed with mesothelioma, a rare cancer caused by exposure to asbestos.

View the full article

Oct 4, 2010 - London Study Shows Benefit of Surgery for Mesothelioma

Researchers from the University College London concluded that there is a benefit of longer survival times and increased quality of life for mesothelioma patients who undergo surgery, however risks must be weighed in when choosing this as a treatment strategy.

View the full article

Oct 3, 2010 - NK4 Antagonist Suppresses Mesothelioma Cell Growth

NK4 is an agent that prevents tumor growth and motility in mesothelioma patients and warrants further research into its therapuetic effectiveness for this rare cancer caused by exposure to asbestos.

View the full article

Sep 30, 2010 - NewlyTechnology Shows Signs of Detecting Mesothelioma and Pancreatic Cancer At Early Stages

SomaLogic, Inc. announced that findings of unique biomarkers and protein signatures in mesothelioma and pancreatic cancers that can lead to more accurate and earlier diagnosis of these rare malignancies.

View the full article

Sep 24, 2010 - Targeted Therapy for Malignant Pleural Mesothelioma

Targeted therapy for malignant pleural mesothelioma (MPM) uses often uses anti-cancer drugs that interfere or interrupt the progression or proliferation of malignant cells.

View the full article

Sep 21, 2010 - Maintenance Therapy for Mesothelioma

Maintenance therapy for mesothelioma is the treatment one receives after initial procedures are taken, such as surgery or chemotherapy.

View the full article

Sep 17, 2010 - Anemia as a Result of Mesothelioma Treatment

Anemia, a common side effect from mesothelioma treatments, should be prevented and managed to prevent fatigue and keep optimal quality of life.

View the full article

Sep 15, 2010 - Study Shows Vitamin Supplementation Has No Effect on Mesothelioma

For decades research has been investigating whether the use of vitamin A supplementation could prevent the development of mesothelioma, a rare cancer caused by exposure to asbestos, with latest results showing no beneficial effect.

View the full article

Sep 15, 2010 - T-Cell Immunotherapy for Treating Mesothelioma

A study exploring immunotherapy for patients diagnosed with malignant pleural mesothelioma using CD8+ T-cells indicates a more favorable prognosis and warrants more research.

View the full article

Sep 10, 2010 - Tunica Vaginalis Mesothelioma Malignancy Differs Than Other Types

Tunica Vaginalis mesothelioma is one of the most rare forms of mesothelioma, an incurable cancer caused by exposure to asbestos.

View the full article

Sep 9, 2010 - Managing Side Effects of Radiation for Mesothelioma

Radiation is a standard treatment for mesothelioma, a rare cancer caused by exposure to asbestos. Here we discuss tips for managing and easing the side effects that come from radiation therapy.

View the full article

Sep 9, 2010 - Best Nutrition Practices for Mesothelioma Patients

Eating well and following recommended dietary guidelines can help to ease discomfort and increase response to treatments, improving overall quality of life, for mesothelioma patients.

View the full article

Sep 7, 2010 - Mesothelioma Related Fatigue

Anyone diagnosed and undergoing treatment for mesothelioma knows that fatigue is common, both for patient and caregivers. Here are some techniques that can help to alleviate cancer-related fatigue.

View the full article

Sep 7, 2010 - Techniques to Help Cope with Mesothelioma

Symptoms of mesothelioma can be painful and scary and treatments to help alleviate the symptoms can cause stress and anxiety. Here are a few techniques to help cope if you have been diagnosed with mesothelioma.

View the full article

Sep 2, 2010 - Mesothelin and Mesothelioma: Tumor Marker and Disease Protector

Research has been investigating the use of mesothelin as a tumor marker for and disease protector against mesothelioma, a rare cancer caused by exposure to asbestos.

View the full article

Aug 28, 2010 - Interoperative Hyperthermic Chemotherapy for Mesothelioma

A recent clinical trial investigating pleural cancer treatments shows that interoperative hyperthermic chemotherapy, in which drugs are delivered concurrently with surgery, creates higher survival rates for patients diagnosed with mesothelioma.

View the full article

Aug 27, 2010 - New Medical Research for Assessing Mesothelioma

Two new clinical trials, one from the Princess Margaret Hospital in Ontario, Canada, and the other from the Vanderbilt School of Medicine in Tennessee, have had promising results in more effectively understanding and treating mesothelioma.

View the full article

Aug 21, 2010 - The Support Person for Someone Diagnosed with Mesothelioma

The primary support person for someone diagnosed with mesothelioma needs to take care of and get support themselves as the experience can be very challenging on many levels.

View the full article

Aug 19, 2010 - Virotherapy for Mesothelioma

Virotherapy is an alternative form of treatment that is being investigated to slow progression and increase survival time for patients diagnosed with mesothelioma, an incurable cancer caused by asbestos exposure.

View the full article

Aug 19, 2010 - Mesothelioma Resistance to Standard Chemotherapy Drugs

Malignant pleural mesothelioma is a fatal neoplasm cause primarily by asbestos exposure. Mesothelioma historically and currently is often resistant to standard chemotherapy drugs so more effective alternatives are being researched.

View the full article

Aug 15, 2010 - Understanding Mesothelioma and Its Multi-Level Impact

Mesothelioma, a cancer caused by exposure to asbestos, affects patients and loved ones on multidimensional levels.

View the full article

Aug 6, 2010 - Modified Herpes Vaccine Helps Fight Mesothelioma

Oncolytic viruses, such as modified herpes vaccines, are being tested in clinical trials and show promise as alternative treatment for mesothelioma.

View the full article

Jul 23, 2010 - Standard Multimodality Treatment for Mesothelioma

The standard treatment for mesothelioma is usually a combination approach of surgery, chemotherapy and radiation therapy.

View the full article

Jul 20, 2010 - Thorancentesis: First Treatment of Pleural Mesothelioma

Thorancentesis is one of the first diagnostic tools as well as palliative treatment procedures for those suffering from malignant pleural mesothelioma.

View the full article

Jul 20, 2010 - Pleurodesis and Intrapleural Catheters: Palliative Treatment for Mesothelioma

Two most common palliative treatments of malignant pleural mesothelioma that can relieve pain and symptoms is pleurodesis and intrapleural catheters.

View the full article

Jul 19, 2010 - Diagnosis of Malignant Pleural Mesothelioma

Symptoms of pleural effusion prompt initial assessment of malignant mesothelioma, which begins with several diagnostic steps.

View the full article

Jul 14, 2010 - Peritoneal Mesothelioma with Low Level Asbestos Exposure

Data from clinical trials indicate that peritoneal mesothelioma, a cancer that develops in the lining of the abdomen, can occur even at low levels of exposure to asbestos.

View the full article

Jul 11, 2010 - Clinical Trail Investigates Immunotherapy as Treatment for Mesothelioma

University of Pennsylvania conducted a phase I clinical trial that showed that giving two doses of IFN-betas was a safe and effective approach to treating mesothelioma tumors.

View the full article

Jul 1, 2010 - Therapies Targeting Mesothelioma Investigated

Standard treatments for mesothelioma have not been very effective so researchers continue to investigate alternatives that may slow or stop mesothelioma tumor growth.

View the full article

Jun 21, 2010 - Malignant Mesothelioma of the Omentum

A recent study from Queen Mary's Hospital recommends adding omental mesothelioma, a rare form of peritoneal mesothelioma, as part of making a differential diagnosis.

View the full article

Jun 10, 2010 - Clinical Trail of MORAb-009 to Treat Mesothelioma

The National Cancer Institute is conducting a clinical trial to investigate the effectiveness of MORAb-009 in the treatment of malignant pleural mesothelioma.

View the full article

Jun 1, 2010 - Harvard University Report Studies Mesothelioma Tumor Markers

Researchers from Harvard search for tumor markers for mesothelioma, a rare and aggressive cancer caused by exposure to asbestos.

View the full article

May 30, 2010 - Biology of Malignant Pleural Mesothelioma Provides Treatment Insights

Researchers from Genoa, Italy investigate the biology of mesothelioma cell lines with the goal of identifying markers that would be useful in the diagnosis and prognosis of malignant pleural mesothelioma.

View the full article

May 22, 2010 - Prognostic Markers for Malignant Pleural Mesothelioma

A Swiss clinical trial explores diagnostic markers that may help identify mesothelioma patients with the best prognosis to help direct treatment efforts.

View the full article

May 16, 2010 - Potential Target for Mesothelioma Treatment

The National Cancer Institute conducts clinical trials investigating potential therapies for all types of cancers, including mesothelioma. Mesothelioma is an incurable cancer that affects the mesothelium, or protective lining around the heart (pericardium), lungs (pleura) or abdomen (peritoneum). Mesothelioma is primarily linked with exposure to asbestos that occurred decades...

View the full article

May 10, 2010 - Mesothelioma Treatment: Managing Side Effects of Radiation Therapy

Radiation therapy for mesothelioma, a cancer caused by exposure to asbestos, has several side effects that can be minimized with good management.

View the full article

May 8, 2010 - Side Effects of Radiology due to Mesothelioma Treatment

Radiation Therapy, often used as a part of the standard regimen for mesothelioma treatments, can cause side effects that are good to know about in advance.

View the full article

May 6, 2010 - Mesothelioma: A Form of Non Small Cell Lung Cancer

Lung cancer is the leading cause of cancer related deaths, with mesothelioma, a malignancy due to asbestos, being one form of non small cell lung cancer.

View the full article

May 4, 2010 - Aurora Kinase Used for Mesothelioma Treatment

Aurora Kinases are overexpressed in mesothelioma cancers and are being researched as possible targets for antitumor drug treatment regimens.

View the full article

May 3, 2010 - Radiotherapy Induced Nausea from Mesothelioma Treatments

Nausea and vomiting are common side effects of radiation, which is almost always recommended as part of a mesothelioma treatment plan. Taking measures to reduce the severity of side effects is crucial.

View the full article

Apr 26, 2010 - Alternative Botanical Medicine to Treat Mesothelioma

A recent study investigated the use of an extract of Carica papaya as a botanical remedy against cancers, including lung cancers such as mesothelioma.

View the full article

Apr 23, 2010 - Peritoneal Mesothelioma

Peritoneal mesothelioma is one form of this rare and aggressive cancer caused by exposure to asbestos.

View the full article

Apr 23, 2010 - Computed Tomography Correlated with Histology of Mesothelioma

A study from University of British Columbia investigated the correlation between CT imaging and histology of mesothelioma in hopes of finding more effective ways of guiding treatment.

View the full article

Apr 15, 2010 - Treatment Options for Advanced Mesothelioma (Stages II, III, and IV)

Mesothelioma caused by asbestos is usually not diagnosed until it has reached advanced stages. Several treatment options exist depending on the stage, type and location of mesothelioma.

View the full article

Apr 14, 2010 - Multimodality Treatment for Mesothelioma

Recent research reviewing 30 years of treatment studies proves that a multimodality approach to treating mesothelioma leads to best survival rates and quality of life.

View the full article

Apr 12, 2010 - Prognosis of Mesothelioma Due to Asbestos Exposure

Mesothelioma is caused by exposure to asbestos and generally has a poor prognosis. Read more to get a better understanding of what factors are included when making a prognosis for mesothelioma.

View the full article

Apr 11, 2010 - Treatment of Recurrent Mesothelioma Due to Asbestos

Recurrent mesothelioma is quite common so researchers are investigating ways to re-treat the disease to enhance quality of life and lengthen survival times.

View the full article

Apr 11, 2010 - Screening for Mesothelioma

Researchers are studying new and more effective ways of screening for mesothelioma in efforts to catch the cancer in earlier stages.

View the full article

Mar 30, 2010 - RNA molecules May Help with Mesothelioma Prognosis

A recent study points to the potential of a microRNA molecule, has-miR-29c, to be used as a prognostic tool in mesothelioma cancers.

View the full article

Mar 26, 2010 - Patient Perspective- Part 4: Psychosocial Effects of Mesothelioma

This is the last of a series of articles discussing what it's like to have mesothelioma from the patient's perspective. This final article is about the psychosocial effects, especially when it comes to mesothelioma symptoms, treatments, and side effects.

View the full article

Mar 23, 2010 - Patient Perspective- Part 3: Medical Treatments for Mesothelioma

Deciding on which treatments, going through them, and finding ways to cover the costs of treatments for mesothelioma, a cancer caused by exposure to asbestos, can be distressing and overwhelming according to many patients.

View the full article

Mar 22, 2010 - Dyspnea: Main Symptom of Mesothelioma

Dyspnea is a common and often frightening symptom of mesothelioma, a rare form of cancer caused by exposure to asbestos.

View the full article

Mar 19, 2010 - Patient Perspective- Part 2: Coping with Symptoms of Mesothelioma

Brief description of what it's like to cope with the symptoms of mesothelioma due to asbestos exposure from patients' perspectives.

View the full article

Mar 15, 2010 - Patient Perspective- Part 1: Being Diagnosed with Mesothelioma

Coping with a diagnosis of mesothelioma is the first of a four part series that discusses what it's like to be diagnosed with malignant mesothelioma from the patients' perspective.

View the full article

Mar 8, 2010 - Promising Vaccine for Mesothelioma under Investigation

Researchers from the Netherlands recently published results from a study that shows promising results of a mesothelioma vaccine that may have therapeutic effects.

View the full article

Mar 4, 2010 - Importance of Early Diagnosis of Mesothelioma

Early diagnosis of mesothelioma is key in treatment and management of the disease. Research is ongoing to discover markers that could accurately identify and distinguish mesothelioma from other types of cancer.

View the full article

Mar 2, 2010 - Gene Therapy Studies for Mesothelioma Treatment

One novel type of treatment being tested on mesothelioma is gene therapy, which aims to replace the genes in cancer cells with healthy genes. Two recent studies show some promising results.

View the full article

Feb 19, 2010 - T3 Promising Agent for Reducing Chemo Resistance in Mesothelioma

A recent study looked at the use of tocotrienol (T3), a food-derived oil and rich, nonsaturated form of vitamin E, as an effective agent to reduce chemoresistance in mesothelioma.

View the full article

Feb 11, 2010 - Measuring Response to Therapy in Malignant Pleural Mesothelioma

A recent study published in Lung Cancer (March 2010) explored which parameters would be best to use in evalutaing treatment response in patients diagnosed with malignant pleural mesothelioma.

View the full article

Feb 4, 2010 - Review of Current Treatments for Malignant Mesothelioma

The standard form of treatment for malignant plueral mesothelioma is fairly well established, although research continues due to limited effectiveness and also exploring second line treatments.

View the full article

Jan 29, 2010 - Sirolimus Causes Cell Death in Mesothelioma

Standard treatments for malignant pleural mesothelioma, a cancer primarily caused by exposure to asbestos, have not been very effective. One novel approach being investigated is combining sirolimus with a common chemotherapy drug, Cisplatin, to see if treatment might not improve.

View the full article

Jan 15, 2010 - Novel Mesothelioma Treatment Protects Cells from Apoptosis

Apoptosis is a process which causes cell death. Researchers have investigated the role apoptosis plays in mesothelioma cancers and if certain factors couldn't be employed for therapeutic intervention.

View the full article

Jan 11, 2010 - Scottish Ruling a Win for Asbestos and Mesothelioma Sufferers

Asbestos victims suffering from pleural plaques are pleased with the Scottish Court's decision to overturn a House of Lords ruling that left them without access to insurance compensation despite their medical condition.

View the full article

Jan 10, 2010 - Novel Mesothelioma Treatment using ATRA

ATRA, an all-trans-retonic acid, is being studied as a viable option for helping treat mesothelioma as an inhibitor of tumor growth and slowing the progression of the disease.

View the full article

Jan 8, 2010 - Novel Tumor Suppressor for Mesothelioma

Results from a recent study have shown promising results with the use of a novel agent, FUS1/TUSC2 in targeting molecular pathways to inhibit the proliferation and survival of tumor cells and is worthy of further investigation as an effective mesothelioma treatment option.

View the full article

Jan 8, 2010 - Former Football Star Sues over Mesothelioma

Merlin Olsen, former football player for the Los Angeles Rams, is suing asbestos manufacturers and NBC Studios after being diagnosed with malignant pleural mesothelioma last summer.

View the full article

Sep 25, 2009 - Mesothelioma Lawsuit Ends with $1.4 Million Verdict for Wife

Marian Jackson, surviving spouse of Kenneth Wayne Jackson, received a $1.4 million dollar asbestos award. Mr. Jackson died of mesothelioma caused by occupational exposure to asbestos products manufactured or supplied by North Brothers while working for Combustion Engineering as a pipefitter.

View the full article

Sep 17, 2009 - Facing a Mesothelioma Diagnosis

When given a diagnosis of mesothelioma, there are certain steps one can take that will make the process of coping with a terminal illness easier and ensure that medical costs get covered by insurance and/or by a successful asbestos lawsuit.

View the full article

Jul 29, 2009 - University Researches Mesothelioma in Iron Range Workers

The University of Minnesota is seeking current and former taconite employees of the Mesabi Iron Range to conduct a study to explore the high rates of mesothelioma deaths in the region.

View the full article

Jul 16, 2009 - Exposure to Asbestos and Mesothelioma Continue

Lung cancer is the leading cause of cancer deaths in the United States. Mesothelioma is a form of non-small cell lung cancer that is caused by exposure to asbestos. Malignant mesothelioma rates are expected to peak in 2010, according to the Center for Disease Control.

View the full article

Jun 25, 2009 - Reducing Post-Chemotherapy Nausea for Mesothelioma Patients

Treatment of mesothelioma, a rare form of cancer caused by exposure to asbestos, often includes some form of chemotherapy. Many patients who receive chemotherapy also experience severe stomach upset and nausea. A recent study finds that taking ginger supplements before and after such treatments can greatly reduce these symptooms.

View the full article

Jun 24, 2009 - Complementary Therapy Treatments for Mesothelioma: Explanation of Terms

Mesothelioma is a rare form of cancer caused primarily by exposure to asbestos. Along with standard therapies, such as surgery, chemotherapy and radiation, there are many complementary and alternative treatments that can be integrated with conventional ones to improve overall quality of life.

View the full article

Jun 11, 2009 - The Asbestos and Mesothelioma Weekly News

An overview of asbestos and mesothelioma, and this weeks related current news.

View the full article

Apr 10, 2009 - Mesothelioma and Asbestos: Headline News

Recapping the most relevent news regarding asbestos use, asbestos exposure, and mesothelioma, this summary gives brief descriptions of what has happened over the last week.

View the full article

Feb 25, 2009 - Treatment Results for Young Mesothelioma Patients

Four adolescent patients diagnosed with peritoneal mesothelioma were selected for a study to gain understanding about the deadly disease, improve diagnosis techniques, and discover best treatment options to extend survival times.

View the full article

Feb 10, 2009 - Hopeful Research for Mesothelioma Sufferers

Two studies offered hope for those suffering from mesothelioma, a cancer of the lining of the lungs or abdomen primarily caused by exposure to asbestos. The results of the studies may lead to prolonging the life of patients diagnosed with mesothelioma, and possibly a cure for the fatal disease.

View the full article

Jan 2, 2009 - Father Dies of Mesothelioma - Sons File Suit against Chevron

Four sons of a deceased refinery worker file a wrongful death suit against Chevron and Gulf Oil on behalf of their father, Gliese Bergeron.

View the full article

Dec 19, 2008 - Hope for Woman Diagnosed with Mesothelioma

In most cases, a patient diagnosed with mesothelioma has a grim prognosis of any kind of treatment or cure. Debbie Brewer proves to be an exception. She was diagnosed in November of 2006 due to secondary exposure caused by hugging her father when he returned home from working in the ship yards. Debbie was given less than a year to live, but then chose to try an experimental treatment,...

View the full article

Dec 19, 2008 - How Exposure to Asbestos Leads to Cancer

Scientists from Ohio State are studying how asbestos fibers can cause cancers such as mesothelioma. Studies have been done previously, but never looking at the interactions between asbestos fibers and human cells. The intention of the research is to help treat and prevent asbestos-induced diseases.

View the full article

Oct 1, 2008 - FDA Widens Use of Eli Lilly Cancer Drug

The Food & Drug Administration has approved the use of the Eli Lilly drug Alimta as a fist-line treatment for both advanced and metastasized non-small cell lung cancer. Alimta was previously approved as a secondary treatment for non-small cell lung cancer with chemotherapy and as a treatment for malignant mesothelioma.

View the full article

Sep 24, 2008 - September 26 To Be Mesothelioma Awareness Day

Two women of Carbondale, Illinois, are campaigning to establish "Mesothelioma Awareness Day" across the nation on September 26.

View the full article

Sep 1, 2008 - Mesothelioma Attorneys Encouraged by Lovastatin as Pleural Meso Treatment

Lovastatin, a drug introduced in 1980 as a treatment for high levels of cholesterol, shows promise for potential use against pleural mesothelioma, a deadly form of cancer caused by asbestos exposure.

View the full article

Aug 15, 2008 - W. R. Grace Appeal Denied; Mesothelioma Epidemic Feared

The Montana Supreme Court has denied an appeal by W.R. Grace Company relating to charges of improper disposal of asbestos-containing materials in Libby, Montana. More recently, physicians and mesothelioma attorneys familiar with the asbestos exposure from the company's mining activities predict there will be an epidemic of mesothelioma among area residents over the next 20 years.

View the full article

Aug 15, 2008 - New MicroRNA Test for Pleural Mesothelioma

A new form of diagnostic testing, known as microRNA, provides "advanced sensitivity" compared to tests now available, according to Rosetta Genomics of Israel, developers of the test.

View the full article

Aug 4, 2008 - Two New Drugs Help Against Pleural Mesothelioma

A combination of the cancer drugs navelbine (vinorelbine) and platinol (cisplatin) are "highly reactive" when treating patients with "newly diagnosed non-resectable malignant pleural mesothelioma," according to a recent study conducted in Denmark.

View the full article

Jul 21, 2008 - A New Protocol Targets Pleural Mesothelioma

July 21 -- A new, targeted radiation and chemotherapy protocol for pleural mesothelioma is underway at the Mesothelioma Center at New York Presbyterian Hospital and Columbia University Medical Center. "We will investigate whether a combination of chemotherapy and radiation targeted directly to the lung lining can improve outcomes while avoiding surgery," according to Dr. Robert Taub, director...

View the full article

Sep 26, 2007 - ASBESTOS TAKEN HOME FROM WORK CAUSES MESOTHELIOMA IN HOUSEWIVES

Asbestos lawyers are filing lawsuits against the employers of workers because of secondhand exposure to asbestos brought into the home on clothing. In a typical case, the worker is male and s exposed to asbestos at his workplace. The asbestos fibers cling to his work clothes which he brings home. His wife lauders the clothes and is exposed to asbestos by doing so. The wife develops...

View the full article